| PERIOD ENDING | 26-Apr-09 | 25-Jan-09 | 26-Oct-08 | 27-Jul-08 | | Total Revenue | 664,231 | 481,140 | 897,655 | 892,676 | | Cost of Revenue | 474,535 | 339,474 | 529,812 | 742,759 | | | Gross Profit | 189,696 | 141,666 | 367,843 | 149,917 | | | Operating Expenses | | Research Development | 301,797 | 211,779 | 212,360 | 212,910 | | Selling General and Administrative | 118,864 | 86,440 | 90,349 | 92,399 | | Non Recurring |
-
| 18,530 | 8,338 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (230,965) | (175,083) | 56,796 | (155,392) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,144 | 5,114 | 4,207 | 8,792 | | Earnings Before Interest And Taxes | (224,821) | (169,969) | 61,003 | (146,600) | | Interest Expense |
-
| 406 |
-
|
-
| | Income Before Tax | (224,821) | (170,375) | 61,003 | (146,600) | | Income Tax Expense | (23,483) | (22,710) | (745) | (25,671) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (201,338) | (147,665) | 61,748 | (120,929) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (201,338) | (147,665) | 61,748 | (120,929) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($201,338) | ($147,665) | $61,748 | ($120,929) |
|
0.45% Nasdaq 
0.20%
Income Statement
